Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Metabolic Landscape of Prostate Cancer
Francesca Giunchi, Michelangelo Fiorentino, Massimo Loda
European Urology Oncology (2018) Vol. 2, Iss. 1, pp. 28-36
Closed Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Tumour metabolism and its unique properties in prostate adenocarcinoma
David Bader, Sean E. McGuire
Nature Reviews Urology (2020) Vol. 17, Iss. 4, pp. 214-231
Closed Access | Times Cited: 119
Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications
Ugo Testa, Germana Castelli, Elvira Pelosi
Medicines (2019) Vol. 6, Iss. 3, pp. 82-82
Open Access | Times Cited: 115
Lipid Metabolism and Endocrine Resistance in Prostate Cancer, and New Opportunities for Therapy
Gergana E. Stoykova, Isabel R. Schlaepfer
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2626-2626
Open Access | Times Cited: 95
Metabolic adaptations in prostate cancer
Mikel Pujana-Vaquerizo, Laura Bozal-Basterra, Arkaitz Carracedo
British Journal of Cancer (2024) Vol. 131, Iss. 8, pp. 1250-1262
Open Access | Times Cited: 10
Androgen Receptor Signaling and Metabolic and Cellular Plasticity During Progression to Castration Resistant Prostate Cancer
Takuma Uo, Cynthia C.T. Sprenger, Stephen R. Plymate
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 57
Prostate cancer cell proliferation is influenced by LDL-cholesterol availability and cholesteryl ester turnover
Nikki L. Raftopulos, Tinashe C. Washaya, Andreas Niederprüm, et al.
Cancer & Metabolism (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 31
Engineering the MoS2/MXene Heterostructure for Precise and Noninvasive Diagnosis of Prostate Cancer with Clinical Specimens
Shaowei Xie, Xiaochen Fei, Jiayi Wang, et al.
Advanced Science (2023) Vol. 10, Iss. 15
Open Access | Times Cited: 18
Metabolomics Contributions to the Discovery of Prostate Cancer Biomarkers
Nuria Gómez-Cebrián, Ayelén Rojas‐Benedicto, Arturo Albors-Vaquer, et al.
Metabolites (2019) Vol. 9, Iss. 3, pp. 48-48
Open Access | Times Cited: 52
SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer
Meghan A. Rice, Vineet Kumar, Dhanir Tailor, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 2, pp. 100502-100502
Open Access | Times Cited: 26
From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer
Ekaterina Nevedomskaya, Bernard Haendler
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6281-6281
Open Access | Times Cited: 23
Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers
Baijun Dong, Jun‐Yu Xu, Yuqi Huang, et al.
Nature Cancer (2024) Vol. 5, Iss. 9, pp. 1427-1447
Closed Access | Times Cited: 5
Analysis of fatty acid metabolism in prostate cancer and discovery of a new programmed cell death-associated luminal cell subpopulation
Yan Zeng, Zhen Jiang
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Human Prostate Cancer Is Characterized by an Increase in Urea Cycle Metabolites
András Frankó, Yaping Shao, Martin Heni, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1814-1814
Open Access | Times Cited: 33
The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models
Clara Lemos, Volker Schulze, Simon J. Baumgart, et al.
Cellular Oncology (2021) Vol. 44, Iss. 3, pp. 581-594
Closed Access | Times Cited: 30
Prostate Cancer Energetics and Biosynthesis
Chenchu Lin, Travis C. Salzillo, David Bader, et al.
Advances in experimental medicine and biology (2019), pp. 185-237
Open Access | Times Cited: 32
Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response
Konsta Kukkonen, Sinja Taavitsainen, Laura Huhtala, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3325-3325
Open Access | Times Cited: 26
Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors
Sayani Patra, Naveed Elahi, Aaron Armorer, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 24
Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression
Joanna Łaźniewska, Ka Lok Li, I. R. Johnson, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Metabolomics unveils the exacerbating role of arachidonic acid metabolism in atherosclerosis
Sai Ma, Songqing He, Jing Liu, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 3
Loss of AR-regulated AFF3 contributes to prostate cancer progression and reduces ferroptosis sensitivity by downregulating ACSL4 based on single-cell sequencing analysis
Aoyu Fan, Yunpeng Li, Yunyan Zhang, et al.
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1679-1695
Closed Access | Times Cited: 3
Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification
Eugenio Zoni, Martina Minoli, Cédric Bovet, et al.
BMC Cancer (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 28
Metabolism of prostate cancer by magnetic resonance spectroscopy (MRS)
Uma Sharma, N. R. Jagannathan
Biophysical Reviews (2020) Vol. 12, Iss. 5, pp. 1163-1173
Open Access | Times Cited: 24
Effects of glutamate and aspartate on prostate cancer and breast cancer: a Mendelian randomization study
Yindan Lin, Ze Yang, Jingjia Li, et al.
BMC Genomics (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals
Irma Bisceglia, Maria Laura Canale, Nicola Silvestris, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 8
Plasma Metabolomic Profiles and Risk of Advanced and Fatal Prostate Cancer
Ying Wang, Eric J. Jacobs, Brian D. Carter, et al.
European Urology Oncology (2019) Vol. 4, Iss. 1, pp. 56-65
Closed Access | Times Cited: 24
Page 1 - Next Page

Scroll to top